Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
16
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 16 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Rukobia Fostemsavir Tromethamine | D | $115M | +26% | 1,505 | $76,437 | $147.93 |
| Ketorolac Tromethamine* Ketorolac Tromethamine | D | $35.1M | -13% | 1,030,724 | $34 | $3.16 |
| Fosfomycin Tromethamine Fosfomycin Tromethamine | D | $20.1M | +15% | 71,258 | $283 | $56.97 |
| Valchlor Mechlorethamine HCl | D | $13.9M | +4% | 511 | $27,196 | $101.41 |
| Pyrimethamine Pyrimethamine | D | $8.2M | -2% | 112 | $73,367 | $290.54 |
| Zenith amniotic membrane, per square centimeter · Q4253 | B | $6.0M | -98% | 120 | $49,592 | $259.02 |
| Ethambutol HCl Ethambutol HCl | D | $3.8M | -7% | 16,612 | $228 | $0.66 |
| Sprix Ketorolac Tromethamine | D | $2.0M | -11% | 191 | $10,242 | $503.55 |
| Ketorolac Tromethamine Ketorolac Tromethamine · J1885 | B | $950K | +6% | 338,771 | $3 | $0.66 |
| Ventavis Iloprost Tromethamine · Q4074 | B | $641K | -82% | n/a | n/a | $144.46 |
| Methamphetamine HCl Methamphetamine HCl | D | $207K | +262% | 41 | $5,059 | $10.66 |
| Acuvail Ketorolac Tromethamine/PF | D | $134K | -23% | 131 | $1,025 | $10.81 |
| Alomide Lodoxamide Tromethamine | D | $92K | +43% | 182 | $505 | $19.97 |
| Acular Ketorolac Tromethamine | D | $44K | -41% | 102 | $433 | $42.23 |
| Acular Ls Ketorolac Tromethamine | D | $21K | -12% | 41 | $516 | $45.98 |
| Ethamolin Ethanolamine Oleate · J1430 | B | $14K | -36% | 16 | $844 | $355.36 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.